These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 3311440

  • 1. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
    Ekue JM, Phiri DE, Sheth UK, Mukunyandela M.
    Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
    [Abstract] [Full Text] [Related]

  • 2. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
    de Souza JM, Sheth UK, Wernsdorfer WH, Trigg PI, Doberstyn EB.
    Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438
    [Abstract] [Full Text] [Related]

  • 3. A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.
    de Souza JM, Sheth UK, de Oliveira RM, Gomes AT, Cavalcante EQ.
    Bull World Health Organ; 1985; 63(3):611-5. PubMed ID: 3899398
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria.
    Botero D, Restrepo M, Montoya A.
    Bull World Health Organ; 1985; 63(4):731-7. PubMed ID: 3910296
    [Abstract] [Full Text] [Related]

  • 8. Falciparum malaria treated with a fixed combination of mefloquine, sulfadoxine and pyrimethamine: a field study in adults in Burma.
    Tin F, Hlaing N, Tun T, Win S, Lasserre R.
    Bull World Health Organ; 1985; 63(4):727-30. PubMed ID: 2935320
    [Abstract] [Full Text] [Related]

  • 9. A phase I clinical trial of mefloquine in Brazilian male subjects.
    de Souza JM.
    Bull World Health Organ; 1983; 61(5):809-14. PubMed ID: 6360400
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A phase II clinical trial of mefloquine in Brazilian male subjects.
    de Souza JM.
    Bull World Health Organ; 1983; 61(5):815-20. PubMed ID: 6360401
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phase III double-blind comparative study of Fansimef and Lariam for the curative treatment of Plasmodium falciparum infections in Thailand.
    Thimasarn K, Pinichpongse S, Malikul S, Rooney W, Tansophalaks S.
    Southeast Asian J Trop Med Public Health; 1990 Sep; 21(3):404-11. PubMed ID: 2075482
    [Abstract] [Full Text] [Related]

  • 20. Fansimef [Fansidar plus mefloquine] is effective treatment for imported malaria in New Zealand.
    Ellis-Pegler RB, Beeching NJ, Eales M, Fraser AG, Wells AU.
    Aust N Z J Med; 1988 Aug; 18(5):733-4. PubMed ID: 3072955
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.